Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival Article

Sperduto, Paul W, Mesko, Shane, Li, Jing et al. (2020). Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival . NEURO-ONCOLOGY, 22(9), 1359-1367. 10.1093/neuonc/noaa025

Open Access International Collaboration

cited authors

  • Sperduto, Paul W; Mesko, Shane; Li, Jing; Cagney, Daniel; Aizer, Ayal; Lin, Nancy U; Nesbit, Eric; Kruser, Tim J; Chan, Jason; Braunstein, Steve; Lee, Jessica; Kirkpatrick, John P; Breen, Will; Brown, Paul D; Shi, Diana; Shih, Helen A; Soliman, Hany; Sahgal, Arjun; Shanley, Ryan; Sperduto, William; Lou, Emil; Everett, Ashlyn; Boggs, Drexell Hunter; Masucci, Laura; Roberge, David; Remick, Jill; Plichta, Kristin; Buatti, John M; Jain, Supriya; Gaspar, Laurie E; Wu, Cheng-Chia; Wang, Tony JC; Bryant, John; Chuong, Michael; Yu, James; Chiang, Veronica; Nakano, Toshimichi; Aoyama, Hidefumi; Mehta, Minesh P

sustainable development goals

authors

publication date

  • September 1, 2020

published in

keywords

  • CARCINOMA
  • Clinical Neurology
  • DISEASE
  • ESTROGEN-RECEPTOR
  • EVOLUTION
  • GRADED PROGNOSTIC ASSESSMENT
  • IMPACT
  • Life Sciences & Biomedicine
  • MARKERS
  • Neurosciences & Neurology
  • Oncology
  • PROGESTERONE-RECEPTOR
  • Science & Technology
  • THERAPY
  • WOMEN
  • brain metastases
  • breast cancer
  • estrogen/progesterone/HER2 receptor discordance

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 1359

end page

  • 1367

volume

  • 22

issue

  • 9